Reports have emerged of 18 separate liver injuries to consumers, caused by taking products containing turmeric supplements, specifically the Curcuma longa species.
Of the 18 injuries, two were classed as ‘severe’ by regulator the Therapeutic Goods Administration (TGA), while one ended in a fatality. To read the full report, click here.
A TGA spokesperson said: “The risk may be higher for products with enhanced absorption or bioavailability and/or higher doses. People with existing or previous liver problems may be more likely to develop this rare adverse event.”
They continued: “However, there is not enough information at this time to conclusively identify which medicines are higher risk.”
People with existing or previous liver problems may be more likely to develop this rare adverse event
- Therapeutic Goods Administration
The TGA has issued advice to both medical professionals and consumers to be wary of turmeric supplements. Warning signs include yellowing of the skin or eyes, dark urine, nausea, vomiting, unusual tiredness, weakness, stomach or abdominal pain, or loss of appetite.
The same risks are also related to other ingredients from the same species, including Curcuma zanthorrhiza, Curcuma zedoaria and Curcuma aromatica.
Conversely, the agency has assured the public the risk does not relate to consuming turmeric in typical dietary amounts.
The TGA said it would continue monitoring the situation and is considering regulatory action such as recommending a warning label be applied to products.